• Return to Headlines

Foundation Medic Shares Up 73.1% Since SmarTrend's Buy Recommendation (FMI)

By David Diaz

SmarTrend identified an Uptrend for Foundation Medic (NASDAQ:FMI) on May 16th, 2018 at $79.15. In approximately 15 months, Foundation Medic has returned 73.08% as of today's recent price of $137.00.

In the past 52 weeks, Foundation Medic share prices have been bracketed by a low of $136.75 and a high of $137.00 and are now at $137.00, 0% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Foundation Medicine, Inc. develops cancer diagnostic technology. The Company offers cancer genomics laboratory tests enabling the personalization of cancer treatments. Foundation Medicine serves the biomedical sector in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Foundation Medic shares.

Log in and add Foundation Medic (FMI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights foundation medic

Ticker(s): FMI